SUPN
Supernus Pharmaceuticals Inc
Price:  
26.91 
USD
Volume:  
443,179.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SUPN EV/EBITDA

-58.8%
Upside

As of 2024-06-25, the EV/EBITDA ratio of Supernus Pharmaceuticals Inc (SUPN) is 15.45. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SUPN's latest enterprise value is 1,415.84 mil USD. SUPN's TTM EBITDA according to its financial statements is 91.65 mil USD. Dividing these 2 quantities gives us the above SUPN EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 10.3x - 13.5x 11.9x
Forward P/E multiples 11.1x - 12.2x 11.9x
Fair Price 1.18 - 23.73 11.09
Upside -95.6% - -11.8% -58.8%
26.91 USD
Stock Price
11.09 USD
Fair Price

SUPN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-25 15.21
2024-06-24 15.45
2024-06-21 15.53
2024-06-20 15.38
2024-06-18 15.30
2024-06-17 14.90
2024-06-14 14.90
2024-06-13 15.24
2024-06-12 15.55
2024-06-11 15.02
2024-06-10 15.02
2024-06-07 15.06
2024-06-06 15.59
2024-06-05 15.83
2024-06-04 16.05
2024-06-03 15.87
2024-05-31 15.57
2024-05-30 15.24
2024-05-29 15.24
2024-05-28 15.54
2024-05-24 15.81
2024-05-23 15.96
2024-05-22 16.02
2024-05-21 16.13
2024-05-20 16.56
2024-05-17 16.76
2024-05-16 16.80
2024-05-15 16.55
2024-05-14 16.68
2024-05-13 17.11
2024-05-10 16.68
2024-05-09 17.30
2024-05-08 18.08
2024-05-07 17.99
2024-05-06 17.55
2024-05-03 17.80
2024-05-02 17.46
2024-05-01 17.35
2024-04-30 17.36
2024-04-29 17.66
2024-04-26 17.34
2024-04-25 16.89
2024-04-24 17.46
2024-04-23 17.27
2024-04-22 17.13
2024-04-19 16.94
2024-04-18 16.62
2024-04-17 16.70
2024-04-16 16.96
2024-04-15 17.30